The Effect Observation of Lianhua Qingwen Granule in the Adjuvant Treatment of Community Acquired Pneumonia (CAP)
Abstract
Objective To observe the efficacy of Lianhua Qingwen Granule in the adjuvant treatment of community-acquired pneumonia (CAP). Methods From March 2018 to January 2020, adult patients with CAP who visited the internal medicine clinic of community health service center of Minzu University of China were divided by a random code list into two groups: the observation group (31cases), Lianhua Qingwen Granule orally combined with Levofloxacin intravenous drop, The control group (31 cases), Levofloxacin intravenous drop alonely. The cough symptom score, the cough visual simulation score (VAS), antipyretic time and X-ray chest shadow absorption were compared between the two groups to judge the curative effect. Measurement data were expressed as mean±standard deviation, and comparison used independent sample t test. Enumeration data were expressed as percentages, total effective rates were compared by χ2 tests. Results There were no statistically significant differences in baseline data, such as age, score of cough symptom before treatment between the two groups. Compared with the control group, cough symptom score and VAS of observation group decreased significantly [(2.45±1.312) point vs (3.61±1.476) point, P=0.002], [(3.68±1.973) point vs (4.84±1.753) point, P=0.017], antipyretic time was decreased significantly [(3.00 ±1.4814) day VS (4.842±1.5728) day, P=0.001], effective rate was increased significantly (87.1% VS 64.5%, P=0.038). Compliance: the rate of hospital transfer without…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.